Response to Comments on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections” - Break, Timothy J; Oikonomou, Vasileios; Dutzan, Nicolas; Desai, Jigar V; Swidergall, Marc; Freiwald, Tilo; Chauss, Daniel; Harrison, Oliver J; Alejo, Julie; Williams, Drake W; Pittaluga, Stefania; Lee, Chyi-Chia R; et al. (Science, 2021)